jewishvoice.blog
No holiday gift for GSK: FDA sends long-acting HIV injectable back to work
HIV patients hunting for relief from the burden of daily pills should wait longer. Saturday, GlaxoSmithKline’s ViiV Healthcare declared that the FDA had rejected its long-acting HIV injection…